Provided by Tiger Fintech (Singapore) Pte. Ltd.

Inovio Pharmaceuticals

1.85
+0.07003.93%
Post-market: 1.890.0426+2.30%19:59 EDT
Volume:504.83K
Turnover:924.66K
Market Cap:67.83M
PE:-0.47
High:1.86
Open:1.80
Low:1.78
Close:1.78
Loading ...

Immune Response Data for Ino-3107 to Be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (Aacr-IO) Conference

THOMSON REUTERS
·
10 Feb

Immune Response Data for INO-3107 to be Presented as a Poster at American Association for Cancer Research Immuno-Oncology (AACR-IO) Conference

PR Newswire
·
10 Feb

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
08 Feb

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
06 Feb

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
04 Feb

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
31 Jan

INOVIO to Participate in the Oppenheimer 35th Annual Healthcare Life Sciences Conference

PR Newswire
·
30 Jan

Inovio Pharmaceuticals Inc. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
·
29 Jan

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors Despite Daily Gains

Dow Jones
·
28 Jan

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
25 Jan

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
22 Jan

Inovio Pharmaceuticals Inc. Stock Outperforms Competitors On Strong Trading Day

Dow Jones
·
17 Jan

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
14 Jan

Inovio price target lowered to $3 from $5 at H.C. Wainwright

TIPRANKS
·
13 Jan

Inovio Pharmaceuticals Inc. Stock Underperforms Friday When Compared To Competitors

Dow Jones
·
11 Jan

Inovio Pharmaceuticals’ Strategic Position Bolstered by INO-3107 Breakthrough and Fast Track Designations

TIPRANKS
·
10 Jan

Inovio CEO sees 2025 to be ‘transformational year’

TIPRANKS
·
09 Jan

INOVIO Highlights Anticipated 2025 Milestones and 2024 Key Accomplishments

PR Newswire
·
09 Jan

Vaccine Stocks Surge: Moderna Jumps 11% as COVID-19 and Flu Fears Reignite Immunization Demand

GuruFocus.com
·
08 Jan

Inovio Pharmaceuticals Inc. Stock Underperforms Monday When Compared To Competitors

Dow Jones
·
07 Jan